Mark Currie

Prior to joining Cyclerion, Currie was SVP, chief scientific officer and president of R&D at Ironwood, where he pioneered the discovery of LINZESS and other GI theapeutic candidates. Before Ironwood, he led discovery groups at Sepracor and Monsanto/Searle, which produced several important medicines, including LUNESTA and CELEBREX.

  • March 2020

Added to: Science Exchange - Palo Alto, CA

Science Exchange provides a scientific R&D services marketplace to enable organizations to connect, collaborate and innovate to more effectively bring new discoveries to market. They have a network of 2,500+ qualified providers offering 7,000+ R&D services.